Filing Details
- Accession Number:
- 0001181431-15-001523
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-27 19:52:31
- Reporting Period:
- 2015-01-23
- Filing Date:
- 2015-01-27
- Accepted Time:
- 2015-01-27 19:52:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
927066 | Davita Healthcare Partners Inc. | DVA | Services-Misc Health & Allied Services, Nec (8090) | 510354549 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1604063 | David Michael Staffieri | C/O Davita Healthcare Partners Inc. 2000 16Th Street Denver CO 80202 | Coo, Kidney Care | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-01-23 | 40,000 | $34.52 | 40,394 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-01-23 | 18,131 | $76.15 | 22,263 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-01-23 | 21,869 | $76.05 | 394 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Rights | Disposition | 2015-01-23 | 40,000 | $0.00 | 40,000 | $34.52 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-09-30 | 2015-09-30 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2014.
- Represents the weighted average sale price of $76.0542. The range of prices for the sale of these shares was $75.76 - $76.26, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- Includes 394 shares that were purchased through the 2014 Employee Stock Purchase Program (ESPP)on 12/31/2014.
- Stock Appreciation Rights, granted on 9/30/2010, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, then 6.25% every three months thereafter.